Skip to content

Effects of Combined Treatment With tDCS and Cognitive Training in Patients With Fibromyalgia

Effects of Combined Treatment With tDCS and Cognitive Training on Attention and Working Memory in Patients With Fibromyalgia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02880917
Enrollment
40
Registered
2016-08-26
Start date
2015-11-30
Completion date
2017-07-10
Last updated
2017-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Keywords

Attention, Memory (short and long-term), Conflict monitoring tasks, Verbal fluency

Brief summary

Chronic pain represents an important health problem responsible for decreases in quality of life, and is associated with great negative impact in society and economy. In many cases, its treatment does not reach therapeutic success causing health professionals and patients dissatisfaction. Chronic pain is also associated with somatization, hopelessness and catastrophizing thinking. These information processing includes sensorial, emotional and cognitive-appraisal thinking, which manifests the working of neural networks at cortical and sub-cortical levels. Attention and memory are a central aspect in the processing of pain modulation. Like in addictions (e.g. smoking, alcohol), chronic pain may debut with displacement in the focus of attention and alterations in the sensorial processing in the incentive-motivation tests. Considering that other studies have indicated that experimental and clinical pain is capable of modulating cognitive activities such as attention,memory and expectation, in this study the investigators will test whether cognitive training, tDCS, or the combination of both interventions decrease cognitive deficits associated with Fibromyalgia

Detailed description

Will be included women aged between 18 and 65 years, chronic pain fibromyalgia according to the criteria of the American College of Rheumatology, pain unresponsive to analgesics such as paracetamol, acetylsalicylic acid, ibuprofen, Carisoprodol, Zanaflex (Tizanidine) and Codeine and give informed consent to participate after initial evaluation. Primary outcome is to Evaluate whether the tDCS associated with cognitive retraining technique is able to modulate attentional bias in fibromyalgia patients. Secondary outcomes are: compare the effect of active tDCS and sham in: Assessed with the Visual Analog Scale for 8 days, Functional capacity, Conditional pain modulation (CPM), Maximal Heat Pain tolerance,Catastrophic thinking,Serum levels of Brain Derived Neurotrophic Factor (BDNF), Beck Depression Inventory, forward and backward digit span( WAIS),Pittsburgh sleep quality and State-Trait Anxiety Inventory (STAI) test.

Interventions

DEVICEtDCS-Sham

Sham tDCS will involve an identical electrode montage, with stimulation ceasing after a 30-second ramp-up period to provide equivalent scalp sensation.

OTHERCognitive training

. The cognitive training consisted of an online application of a Dual N-Back task .The Training will last for 8 days.

tDCS was delivered using the anode electrode positioned over the left dorsolateral prefrontal cortex (DLPFE) and the cathode electrode at supra orbital right region. The electrodes were placed into a 25-35 cm2 square sponge immersed in saline solution for better current conductivity. Current density used was 2 mA and electrodes attached to the scalp were sustained by rubber band.

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
CollaboratorOTHER_GOV
Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil
CollaboratorOTHER
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female patients * literate * right-handed * 18 to 65 years of age * who meet the criteria of the American College of Rheumatology (ACR) for fibromyalgia.

Exclusion criteria

* Pregnant women * Contraindications to tDCS * Metal implant in the brain * History of alcohol or drug abuse in the last six months * History of neurological disorders * Unexplained fainting * Self-reports of head injury or momentary loss of awareness * Neurosurgery. * Will also be excluded patients who have decompensated systemic diseases and / or chronic inflammatory diseases (ex .: lupus, rheumatoid arthritis).

Design outcomes

Primary

MeasureTime frameDescription
Evaluate whether the tdcs associated with cognitive training technique or the combination of both interventions decrease memory deficits associated with Fibromyalgia.8 daysI will use the rey auditory-verbal learning test(RAVLT) to evaluate the memory functions of patients with fibromyalgia, before and after treatment with TDCS and cognitive training.

Secondary

MeasureTime frameDescription
Pain8 daysAssessed with the Visual Analog Scale for 8 days
Scale Functional capacity--(Using The Brazilian Portuguese version of the Profile of Chronic Pain.)2 daysMeasurement of functional capacity pre and pos application tDCS with scale functional capacity in chronic pain.
Test -Conditional pain modulation (CPM)2 days-pre and pos application tDCSThe protocol for heat pain threshold is repeated while the contralateral hand is placed on iced water. The pain due to heat and cold reported on a Visual Analog Scale are recorded.

Other

MeasureTime frameDescription
Pittsburgh sleep quality2 daysMeasurement of Pittsburgh sleep quality pre and pos application tDCS
State-Trait Anxiety Inventory (STAI) test.2 daysMeasurement of State-Trait Anxiety Inventory (STAI) test pre and pos application tDCS
Electroencephalogram/ event-related potential P3002 daysEvaluate event-related potential (P300) pre and pos application tDCS
Maximal Heat Pain Tolerance2 daysAssessed using quantitative sensory testing. Briefly, the thermode placed in subjects forearm is heated until subject reports maximum tolerated pain. A maximal temperature of 52 Celsius has been previously programmed for the device to stop and cool down in order to avoid unintended injuries
Controlled Oral Word Association Test2 daysI will use the Controlled Oral Word Association Test to evaluate the verbal fluency of patients with fibromyalgia, before and after treatment with TDCS and cognitive training.
Forward and backward digit span2 daysI will use the forward and backward digit span to evaluate the working memory of patients with fibromyalgia, before and after treatment with TDCS and cognitive training.
Auditory Consonant Trigrams2 daysI will use the Auditory Consonant Trigrams to evaluate the working memory of patients with fibromyalgia, before and after treatment with TDCS and cognitive training.
Paced Auditory Serial Addiction Test(PASAT)2 daysI will use the Paced Auditory Serial Addiction Test to evaluate the memory functions of patients with fibromyalgia, before and after treatment with TDCS and cognitive training.
Pain catastrophizing thoughts2 daysMeasurement of catastrophic thinking pre and pos application tDCS with catastrophizing.The level of catastrophic thinking will be assessed by the Pain Catastrophizing Scale on Treatment scale.
Serum levels of Brain Derived Neurotrophic Factor (BDNF)2 daysMeasurement of serum levels of BDNF pre and pos application tDCS
Beck Depression Inventory2 daysMeasurement of Beck Depression Inventory pre and pos application tDCS

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026